PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Jingmei Chen

Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmac

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUN 29, 2026 · JOURNAL ARTICLE

Tianhuang Formula and its active ingredient GsRg1 ameliorate central insulin resistance and oxidative stress by enhancing hypothalamic autophagy.

Journal of Ethnopharmacology

Preclinical mechanistic study in animal models and cell cultures demonstrating pathway involvement; lacks clinical efficacy data, human trials, or quantified effect sizes to support clinical translation.

PreliminaryJingmei Chen Obesity Ziyue Huang

Study details

DesignPreclinical mechanistic study combining net…

InterventionTianhuang Formula (THF) and Ginsenoside Rg1…

ComparatorUntreated controls (DIO rat, cell models);…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support